Blood-Cleaning therapy may reduce need for ICU pressor drugs

NCT ID NCT07679555

Recruiting now Knowledge-focused Sponsor: Pest County Flór Ferenc Hospital Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 08, 2026 · Updated 3 times

Summary

This study looks back at medical records of 60 critically ill adults in an intensive care unit who received a blood-cleaning treatment called hemoadsorption. The goal is to see if the therapy helps lower the need for drugs that raise blood pressure, improves lab results, and affects survival. The study does not give any new treatment—it simply analyzes data from routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hemoadsorption (CytoSorb or Efferon LPS cartridge)
What this could lead to: If results are positive, this could point toward a way to reduce the need for blood-pressure-raising drugs in critically ill patients.
What could go wrong: This is a small, single-center observational study, so it cannot prove cause and effect. The therapy may not work for everyone, and results may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOADSORPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMOADSORPTION VASOPRESSOR THERAPY

Contacts and locations

Locations

Pest County Flór Ferenc Hospital, Dept. of Anaesthesiology and Intensive Therapy
RECRUITING

Kistarcsa, Pest County, 2143, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.